Literature DB >> 15156436

Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection.

A C Lankester1, B Heemskerk, E C J Claas, M W Schilham, M F C Beersma, R G M Bredius, M J D van Tol, A C M Kroes.   

Abstract

Adenovirus (AdV) infections are an increasingly frequent and potentially fatal complication in allogeneic stem cell transplant recipients. To determine the antiviral potential of ribavirin in an unbiased way, 4 patients without immune recovery were prospectively analyzed by quantitative measurement of plasma AdV DNA load. Administration of ribavirin at the first signs of AdV dissemination was not accompanied by a decrease in the plasma AdV DNA load in any of these patients, and an increase in the AdV load was even documented in 3. These observations question the potential of ribavirin to improve the outcome for patients with disseminating AdV infection and support a critical evaluation of antiviral treatments for AdV infection that involves the kinetics of virus DNA load as an objective parameter of viral replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15156436     DOI: 10.1086/420817

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  30 in total

1.  Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications.

Authors:  K Ebner; W Pinsker; T Lion
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 2.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Anti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitis.

Authors:  Eiichi Uchio; Aki Fuchigami; Kazuaki Kadonosono; Akio Hayashi; Hiroaki Ishiko; Koki Aoki; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-01-17       Impact factor: 3.117

4.  Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients.

Authors:  Eric C J Claas; Marco W Schilham; Caroline S de Brouwer; Petr Hubacek; Marcela Echavarria; Arjan C Lankester; Maarten J D van Tol; Aloys C M Kroes
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 5.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

Review 6.  Adenovirus infections in immunocompetent and immunocompromised patients.

Authors:  Thomas Lion
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

7.  Antiadenovirus activities of several classes of nucleoside and nucleotide analogues.

Authors:  L Naesens; L Lenaerts; G Andrei; R Snoeck; D Van Beers; Antonin Holy; Jan Balzarini; Erik De Clercq
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

8.  Molecular detection and quantitative analysis of the entire spectrum of human adenoviruses by a two-reaction real-time PCR assay.

Authors:  K Ebner; M Suda; F Watzinger; T Lion
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

9.  Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections.

Authors:  L Lenaerts; E Verbeken; E De Clercq; L Naesens
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

10.  Management of respiratory viral infections in hematopoietic cell transplant recipients.

Authors:  Dimpy P Shah; Shashank S Ghantoji; Victor E Mulanovich; Ella J Ariza-Heredia; Roy F Chemaly
Journal:  Am J Blood Res       Date:  2012-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.